Hyperthermia potentiates oncolytic herpes viral killing of pancreatic cancer through a heat shock protein pathway

Surgery

Volumn 148, Issue 2, 2010, Pages 325-334

  Eisenberg, David P ^a   Carpenter, Susanne G ^b   Adusumilli, Prasad S ^b   Chan, Mei Ki ^b   Hendershott, Karen J ^b   Yu, Zhenkun ^b   Fong, Yuman ^b  

^a HARTFORD HOSPITAL   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 72; ONCOLYTIC VIRUS; SMALL INTERFERING RNA; PRIMER DNA;

APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; GENE SILENCING; HERPES SIMPLEX VIRUS 1; HERPES VIRUS; HUMAN; HUMAN CELL; HYPERTHERMIA; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; UPREGULATION; VIROGENESIS; VIRUS ATTENUATION; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS REPLICATION; DRUG ANTAGONISM; GENETICS; HYPERTHERMIC THERAPY; METABOLISM; MULTIMODALITY CANCER THERAPY; NUCLEOTIDE SEQUENCE; ONCOLYTIC VIROTHERAPY; PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

APOPTOSIS; BASE SEQUENCE; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DNA PRIMERS; GENE KNOCKDOWN TECHNIQUES; HERPESVIRUS 1, HUMAN; HSP72 HEAT-SHOCK PROTEINS; HUMANS; HYPERTHERMIA, INDUCED; ONCOLYTIC VIROTHERAPY; PANCREATIC NEOPLASMS; RNA, SMALL INTERFERING; VIRUS REPLICATION;

EID: 77955301396     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2010.05.005     Document Type: Article

References (66)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M.J. Thun Cancer statistics, 2009 CA Cancer J Clin 59 2009 225 249
2. S.H. Landis, T. Murray, S. Bolden, and P.A. Wingo Cancer statistics, 1999 CA Cancer J Clin 49 1999 8 31
3. L.A. Gloeckler Ries, M.E. Reichman, D.R. Lewis, B.F. Hankey, and B.K. Edwards Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program Oncologist 8 2003 541 552
4. H.K. Weir, M.J. Thun, B.F. Hankey, L.A. Ries, H.L. Howe, and P.A. Wingo Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control J Natl Cancer Inst 95 2003 1276 1299
5. Y. Shaib, J. Davila, C. Naumann, and H. El-Serag The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study Am J Gastroenterol 102 2007 1377 1382
6. R.J. Geer, and M.F. Brennan Prognostic indicators for survival after resection of pancreatic adenocarcinoma Am J Surg 165 1993 68 73
7. V. Heinemann, and S. Boeck Perioperative management of pancreatic cancer Ann Oncol 19 Suppl 7 2008 vii273 vii278
8. J.A. Carr, M. Ajlouni, I. Wollner, D. Wong, and V. Velanovich Adenocarcinoma of the head of the pancreas: effects of surgical and nonsurgical therapy on survival -a ten-year experience Am Surg 65 1999 1143 1149
9. V. Heinemann Gemcitabine in the treatment of advanced pancreatic cancer: a comparative analysis of randomized trials Semin Oncol 29 6 Suppl 20 2002 9 16
10. M. Reinblatt, R.H. Pin, and Y. Fong Herpes viral oncolysis: a novel cancer therapy J Am Coll Surg 205 4 Suppl 2007 S69 S75
11. S. Andreansky, L. Soroceanu, E.R. Flotte, J. Chou, J.M. Markert, and Gillespie Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors Cancer Res 57 1997 1502 1509
12. R. Chambers, G.Y. Gillespie, L. Soroceanu, S. Andreansky, S. Chatterjee, and J. Chou Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma Proc Natl Acad Sci U S A 92 1995 1411 1415
13. A. Chahlavi, T. Todo, R.L. Martuza, and S.D. Rabkin Replication-competent herpes simplex virus vector G207 and cisplatin combination therapy for head and neck squamous cell carcinoma Neoplasia 1 1999 162 169
14. S.J. Advani, S.M. Chung, S.Y. Yan, G.Y. Gillespie, J.M. Markert, and R.J. Whitley Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors Cancer Res 59 1999 2055 2058
15. T. Mineta, S.D. Rabkin, T. Yazaki, W.D. Hunter, and R.L. Martuza Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas Nat Med 1 1995 938 943
16. R.J. Wong, S.H. Kim, J.K. Joe, J.P. Shah, P.A. Johnson, and Y. Fong Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus J Am Coll Surg 193 2001 12 21
17. P.F. McAuliffe, W.R. Jarnagin, P. Johnson, K.A. Delman, H. Federoff, and Y. Fong Effective treatment of pancreatic tumors with two multimutated herpes simplex oncolytic viruses J Gastrointest Surg 4 2000 580 588
18. J.J. Bennett, D.A. Kooby, K. Delman, P. McAuliffe, M.W. Halterman, and H. Federoff Antitumor efficacy of regional oncolytic viral therapy for peritoneally disseminated cancer J Mol Med 78 2000 166 174
19. D.A. Kooby, J.F. Carew, M.W. Halterman, J.E. Mack, J.R. Bertino, and L.H. Blumgart Oncolytic viral therapy for human colorectal cancer and liver metastases using a multimutated herpes simplex virus type-1 (G207) FASEB J 6 1999 1325 1334
20. T. Yazaki, H.J. Manz, S.D. Rabkin, and R.L. Martuza Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1 Cancer Res 55 1995 4752 4756
21. C. Alvarez-Breckenridge, B. Kaur, and E.A. Chiocca Pharmacologic and chemical adjuvants in tumor virotherapy Chem Rev 109 2009 3125 3140
22. X.Q. Lun, J.H. Jang, N. Tang, H. Deng, R. Head, and J.C. Bell Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide Clin Cancer Res 15 2009 2777 2788
23. S.F. Lin, S.P. Gao, D.L. Price, S. Li, T.C. Chou, and P. Singh Synergy of a herpes oncolytic virus and paclitaxel for anaplastic thyroid cancer Clin Cancer Res 14 2008 1519 1528 (Pubitemid 351413937)
24. J. Cinatl Jr., J. Cinatl, M. Michaelis, H. Kabickova, R. Kotchetkov, and J.U. Vogel Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma Cancer Res 63 2003 1508 1514
25. J.J. Bennett, P. Adusumilli, H. Petrowsky, B.M. Burt, G. Roberts, and K.A. Delman Up-regulation of GADD34 mediates the synergistic anticancer activity of mitomycin C and a gamma134.5 deleted oncolytic herpes virus (G207) FASEB J 18 2004 1001 1003
26. M. Aghi, S. Rabkin, and R.L. Martuza Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication J Natl Cancer Inst 98 2006 38 50
27. S.H. Kim, R.J. Wong, D.A. Kooby, J.F. Carew, P.S. Adusumilli, and S.G. Patel Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck Eur J Cancer 41 2005 313 322
28. S.F. Stanziale, H. Petrowsky, J.K. Joe, G.D. Roberts, J.S. Zager, and N.J. Gusani Ionizing radiation potentiates the antitumor efficacy of oncolytic herpes simplex virus G207 by upregulating ribonucleotide reductase Surgery 132 2002 353 359
29. S.V. Blank, S.C. Rubin, G. Coukos, K.M. Amin, S.M. Albelda, and K.L. Molnar-Kimber Replication-selective herpes simplex virus type 1 mutant therapy of cervical cancer is enhanced by low-dose radiation Hum Gene Ther 13 2002 627 639
30. S.M. Chung, S.J. Advani, J.D. Bradley, Y. Kataoka, K. Vashistha, and S.Y. Yan The use of a genetically engineered herpes simplex virus (R7020) with ionizing radiation for experimental hepatoma Gene Ther 9 2002 75 80
31. D.P. Eisenberg, P.S. Adusumilli, K.J. Hendershott, Z. Yu, M. Mullerad, and M.K. Chan 5-fluorouracil and gemcitabine potentiate the efficacy of oncolytic herpes viral gene therapy in the treatment of pancreatic cancer J Gastrointest Surg 9 2005 1068 1077
32. R.M. Smeenk, V.J. Verwaal, N. Antonini, and F.A. Zoetmulder Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy Ann Surg 245 2007 104 109
33. J. Esquivel, R. Sticca, P. Sugarbaker, E. Levine, T.D. Yan, and R. Alexander Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology Ann Surg Oncol 14 2007 128 133
34. T.R. Tilleman, W.G. Richards, L. Zellos, B.E. Johnson, M.T. Jaklitsch, and J. Mueller Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study J Thorac Cardiovasc Surg 138 2009 405 411
35. A. Di Giorgio, E. Naticchioni, D. Biacchi, S. Sibio, F. Accarpio, and M. Rocco Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer Cancer 113 2008 315 325
36. S. Adachi, S. Kokura, T. Okayama, T. Ishikawa, T. Takagi, and O. Handa Effect of hyperthermia combined with gemcitabine on apoptotic cell death in cultured human pancreatic cancer cell lines Int J Hyperthermia 25 2009 210 219
37. T. Ohguri, H. Imada, K. Yahara, H. Narisada, T. Morioka, and K. Nakano Concurrent chemoradiotherapy with gemcitabine plus regional hyperthermia for locally advanced pancreatic carcinoma: initial experience Radiat Med 26 2008 587 596
38. S.H. Thorne, G. Brooks, Y.L. Lee, T. Au, L.F. Eng, and T. Reid Effects of febrile temperature on adenoviral infection and replication: implications for viral therapy of cancer J Virol 79 2005 581 591
39. Y.S. Haviv, J.L. Blackwell, H. Li, M. Wang, X. Lei, and D.T. Curiel Heat shock and heat shock protein 70i enhance the oncolytic effect of replicative adenovirus Cancer Res 61 2001 8361 8365
40. M.J. Imperiale, H.T. Kao, L.T. Feldman, J.R. Nevins, and S. Strickland Common control of the heat shock gene and early adenovirus genes: evidence for a cellular E1A-like activity Mol Cell Biol 4 1984 867 874
41. J.B. Glotzer, M. Saltik, S. Chiocca, A.I. Michou, P. Moseley, and M. Cotten Activation of heat-shock response by an adenovirus is essential for virus replication Nature 407 6801 2000 207 211
42. N. Tanguy Le Gac, and P.E. Boehmer Activation of the herpes simplex virus type-1 origin-binding protein (UL9) by heat shock proteins J Biol Chem 277 2002 5660 5666
43. M. Kumar, and D. Mitra Heat shock protein 40 is necessary for human immunodeficiency virus-1 Nef-mediated enhancement of viral gene expression and replication J Biol Chem 280 2005 40041 40050
44. R.J. Wong, J.K. Joe, S.H. Kim, J.P. Shah, B. Horsburgh, and Y.M. Fong Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic Metastases Hum Gene Ther 13 2002 1213 1223
45. N. Kemeny, K. Brown, A. Covey, T. Kim, A. Bhargava, and L. Brody Phase I, open-label, dose-escalating study of a genetically engineered herpes simplex virus, NV1020, in subjects with metastatic colorectal carcinoma to the liver Hum Gene Ther 17 2006 1214 1224
46. T.C. Chou, and P. Talalay Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv Enzyme Regul 22 1984 27 55
47. S.M. Wang, J.D. Khandekar, K.L. Kaul, D.J. Winchester, and R.I. Morimoto A method for the quantitative analysis of human heat shock gene expression using a multiplex RT-PCR assay Cell Stress Chaperones 4 1999 153 161
48. J. van der Zee Heating the patient: a promising approach? Ann Oncol 13 2002 1173 1184
49. F.W. Hetzel Biologic rationale for hyperthermia Radiol Clin North Am 27 1989 499 508
50. M.H. Falk, and R.D. Issels Hyperthermia in oncology Int J Hyperthermia 17 2001 1 18
51. J.R. Lepock Cellular effects of hyperthermia: relevance to the minimum dose for thermal damage Int J Hyperthermia 19 2003 252 266
52. M.W. Dewhirst, B.L. Viglianti, M. Lora-Michiels, M. Hanson, and P.J. Hoopes Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia Int J Hyperthermia 19 2003 267 294
53. H.I. Bicher, F.W. Hetzel, T.S. Sandhu, S. Frinak, P. Vaupel, and M.D. O'Hara Effects of hyperthermia on normal and tumor microenvironment Radiology 137 1980 523 530
54. J. Karar, and A. Maity Modulating the tumor microenvironment to increase radiation responsiveness Cancer Biol Ther 8 2009 1994 2001
55. M.B. Meads, R.A. Gatenby, and W.S. Dalton Environment-mediated drug resistance: a major contributor to minimal residual disease Nat Rev Cancer 9 2009 665 674
56. J. Mattiello, F. Hetzel, and L. Vandenheede Intratumor temperature measurements during photodynamic therapy Photochem Photobiol 46 1987 873 879
57. C.W. Song, A. Shakil, R.J. Griffin, and K. Okajima Improvement of tumor oxygenation status by mild temperature hyperthermia alone or in combination with carbogen Semin Oncol 24 1997 626 632
58. P.H. Sugarbaker Surgical treatment of peritoneal carcinomatosis: 1988 Du Pont lecture Can J Surg 32 1989 164 170
59. A.J. Witkamp, E. de Bree, R. van Goethem, and F.A. Zoetmulder Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy Cancer Treat Rev 27 2001 365 374
60. P.H. Sugarbaker, and D. Chang Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy Ann Surg Oncol 6 1999 727 731
61. V.J. Verwaal Cytoreduction and HIPEC for peritoneal carcinomatosis from colorectal origin: the Amsterdam experience Acta Chir Belg 106 2006 283 284
62. B.M. Stiles, P.S. Adusumilli, S.F. Stanziale, D.P. Eisenberg, A. Bhargava, and T.H. Kim Estrogen enhances the efficacy of an oncolytic HSV-1 mutant in the treatment of estrogen receptor-positive breast cancer Int J Oncol 28 2006 1429 1439
63. X.C. Zeng, S. Bhasin, X. Wu, J.G. Lee, S. Maffi, and C.J. Nichols Hsp70 dynamics in vivo: effect of heat shock and protein aggregation J Cell Sci 117 Pt 21 2004 4991 5000
64. M.G. Santoro Heat shock factors and the control of the stress response Biochem Pharmacol 59 2000 55 63
65. M.A. Garcia, P. Gallego, M. Campagna, J. Gonzalez-Santamaria, G. Martinez, and L. Marcos-Villar Activation of NF-kB pathway by virus infection requires Rb expression PLoS ONE 4 2009 e6422
66. P.S. Adusumilli, B.M. Stiles, M.K. Chan, D.P. Eisenberg, Z. Yu, and S.F. Stanziale Real-time diagnostic imaging of tumors and metastases by use of a replication-competent herpes vector to facilitate minimally-invasive oncological surgery FASEB J 20 2006 726 728